These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 1283939)

  • 1. [Seasonal fluctuations of substance P and vasoactive intestinal peptide concentrations in nasal secretions of patients with nasal allergy to Japanese cedar pollen].
    Mori K; Asakura S; Morikawa N; Chaen T; Watanabe N; Mogi G; Takeyama M
    Arerugi; 1992 Dec; 41(12):1651-7. PubMed ID: 1283939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substance P and vasoactive intestinal peptide in nasal secretions and plasma from patients with nasal allergy.
    Chaen T; Watanabe N; Mogi G; Mori K; Takeyama M
    Ann Otol Rhinol Laryngol; 1993 Jan; 102(1 Pt 1):16-21. PubMed ID: 7678375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Japanese Cedar Pollen-Specific IgA in Nasal Secretions and Nasal Allergy Symptoms.
    Suzuki M; Yokota M; Ozaki S; Matsumoto T; Nakamura Y
    Ann Otol Rhinol Laryngol; 2019 Apr; 128(4):330-337. PubMed ID: 30678469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substance P, calcitonin gene-related peptide, and vasoactive intestinal peptide increase in nasal secretions after allergen challenge in atopic patients.
    Mosimann BL; White MV; Hohman RJ; Goldrich MS; Kaulbach HC; Kaliner MA
    J Allergy Clin Immunol; 1993 Jul; 92(1 Pt 1):95-104. PubMed ID: 7687608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of terfenadine on substance P and vasoactive intestinal polypeptide concentrations in nasal secretions from patients with nasal allergy.
    Takeyama M; Mori K; Morikawa N; Asakura S; Chaen T; Watanabe N; Mogi G
    J Pharm Pharmacol; 1994 Jan; 46(1):41-5. PubMed ID: 7515418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of anti-allergic drugs on substance P (SP) and vasoactive intestinal peptide (VIP) in nasal secretions.
    Shinoda M; Watanabe N; Suko T; Mogi G; Takeyama M
    Am J Rhinol; 1997; 11(3):237-41. PubMed ID: 9209598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical effects of immunotherapy on Japanese cedar pollinosis in the season of cedar and cypress pollination.
    Ito Y; Takahashi Y; Fujita T; Fukuyama S
    Auris Nasus Larynx; 1997 Apr; 24(2):163-70. PubMed ID: 9134139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The period of termination of nasal symptoms in Japanese cedar pollinosis patients and factors participating in the termination of symptoms].
    Ito Y; Takahashi Y; Matsuura T; Kobayashi M
    Arerugi; 1996 Dec; 45(12):1277-84. PubMed ID: 9133339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of nasal allergen challenge on serotonin, substance P and vasoactive intestinal peptide in plasma and nasal secretions.
    Tønnesen P; Hindberg I; Schaffalitzky de Muckadell OB; Mygind N
    Allergy; 1988 May; 43(4):310-7. PubMed ID: 2455456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The rupture of cedar pollens in nasal secretions].
    Saburi Y; Yazawa A; Sato Y; Ohama E; Saito T
    Nihon Koshu Eisei Zasshi; 1992 Jun; 39(6):341-6. PubMed ID: 1504328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurement of Japanese cedar pollen-specific IgE in nasal secretions.
    Sakaida H; Masuda S; Takeuchi K
    Allergol Int; 2014 Sep; 63(3):467-73. PubMed ID: 24957114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of specific IgE antibodies to Japanese cypress pollen in patients with nasal allergy: a comparative study with Japanese cedar.
    Ganbo T; Hisamatsu K; Inoue H; Kitta Y; Nakajima M; Goto R; Murakami Y
    Auris Nasus Larynx; 1995; 22(3):158-64. PubMed ID: 8561696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific IgE to Japanese cypress (Chamaecyparis obtusa) in patients with nasal allergy.
    Ito H; Nishimura J; Suzuki M; Mamiya S; Sato K; Takagi I; Baba S
    Ann Allergy Asthma Immunol; 1995 Apr; 74(4):299-303. PubMed ID: 7719888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Is the frequency of pre-seasonal manifestation in patients with Japanese cedar pollinosis so high?].
    Okuda M; Ohkubo K; Gotoh M; Ishida Y
    Arerugi; 2005 Jul; 54(7):636-40. PubMed ID: 16229363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative cytology of nasal secretions and scrapings in Japanese cedar pollinosis patients.
    Takeuchi K; Ukai K; Lee HS; Majima Y; Sakakura Y
    Laryngoscope; 1996 Nov; 106(11):1419-23. PubMed ID: 8914913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated levels of interleukin-33 in the nasal secretions of patients with allergic rhinitis.
    Asaka D; Yoshikawa M; Nakayama T; Yoshimura T; Moriyama H; Otori N
    Int Arch Allergy Immunol; 2012; 158 Suppl 1():47-50. PubMed ID: 22627366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [IgG antibody in Japanese cedar pollenosis patients. II. Effects of desensitization and seasonal exposure to cedar pollen on IgG and IgE antibodies in the serum and nasal secretions].
    Ito Y
    Arerugi; 1983 Sep; 32(9):985-95. PubMed ID: 6667129
    [No Abstract]   [Full Text] [Related]  

  • 18. [Increased throat symptoms in Japanese cypress pollinosis].
    Ogihara H; Yuta A; Miyamoto Y; Kitano M; Takeo T; Takeuchi K
    Nihon Jibiinkoka Gakkai Kaiho; 2011 Feb; 114(2):78-83. PubMed ID: 21409844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Major basic protein, eosinophil cationic protein, and arylsulfatase in nasal secretions of patients with Japanese cedar pollinosis.
    Nishioka K; Ogawa T; Saito C; Nishioka S; Nakagawa F; Ohomichi T; Masuda Y
    Acta Med Okayama; 1995 Feb; 49(1):29-33. PubMed ID: 7762407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropeptidergic innervation of human nasal mucosa in various pathological conditions.
    Fang SY; Shen CL
    Proc Natl Sci Counc Repub China B; 1997 Jan; 21(1):8-12. PubMed ID: 9208481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.